Login to Your Account



Study Of Memantine In Pain Misses Primary Endpoints

By Aaron Lorenzo


Thursday, May 8, 2003
Negative trial news Wednesday sent ripples through companies involved in the development of memantine. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription